301 related articles for article (PubMed ID: 29721715)
21. Survival of de novo stage IV breast cancer patients over three decades.
Hölzel D; Eckel R; Bauerfeind I; Baier B; Beck T; Braun M; Ettl J; Hamann U; Harbeck N; Kiechle M; Mahner S; Schindlbeck C; de Waal J; Engel J
J Cancer Res Clin Oncol; 2017 Mar; 143(3):509-519. PubMed ID: 27853869
[TBL] [Abstract][Full Text] [Related]
22. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
23. Overall Survival of Patients With Locoregional and Metastatic Breast Cancer: Is the Influence of Baseline Characteristics the Same?
Gomes I; Aguiar P; Miranda A; Nunes C
Anticancer Res; 2019 Sep; 39(9):5135-5142. PubMed ID: 31519625
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
Kim KN; Qureshi MM; Huang D; Ko NY; Cassidy M; Oshry L; Hirsch AE
Clin Breast Cancer; 2020 Apr; 20(2):e200-e213. PubMed ID: 32089454
[TBL] [Abstract][Full Text] [Related]
25. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
26. Impact of Locoregional Treatment on Prognosis of de novo Stage IV Breast Cancer: A Retrospective Long-Term Study of Chinese Population.
Wang W; Liu J; Wang J; Gao J; Wang X; Wang X
Gynecol Obstet Invest; 2019; 84(3):248-258. PubMed ID: 30448829
[TBL] [Abstract][Full Text] [Related]
27. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
[TBL] [Abstract][Full Text] [Related]
28. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.
Shen T; Gao C; Zhang K; Siegal GP; Wei S
Hum Pathol; 2017 Dec; 70():70-76. PubMed ID: 29031733
[TBL] [Abstract][Full Text] [Related]
29. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Rivera S; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; De La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Courtinard C; Filleron T; Robain M; Dalenc F
Radiother Oncol; 2020 Apr; 145():109-116. PubMed ID: 31931289
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
King TA; Lyman JP; Gonen M; Voci A; De Brot M; Boafo C; Sing AP; Hwang ES; Alvarado MD; Liu MC; Boughey JC; McGuire KP; Van Poznak CH; Jacobs LK; Meszoely IM; Krontiras H; Babiera GV; Norton L; Morrow M; Hudis CA
J Clin Oncol; 2016 Jul; 34(20):2359-65. PubMed ID: 27001590
[TBL] [Abstract][Full Text] [Related]
31. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
[TBL] [Abstract][Full Text] [Related]
32. Validation of the CPS+EG and Neo-Bioscore staging systems after preoperative systemic therapy for breast cancer in a single center in China.
Xu L; Duan X; Zhou B; Liu Y; Ye J; Liu Z; Ma C; Zhang H; Zhang S; Zhang L; Zhao J; Cheng Y
Breast; 2018 Aug; 40():29-37. PubMed ID: 29677568
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients.
Cui H; Ren X; Zhao X; Dai L; Liu D; Bao Y; Hu L; Xiao Z; Ma X; Kang H
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13591-13605. PubMed ID: 37515611
[TBL] [Abstract][Full Text] [Related]
34. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
[TBL] [Abstract][Full Text] [Related]
35. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database.
Li X; Zhang Y; Meisel J; Jiang R; Behera M; Peng L
Breast Cancer Res Treat; 2018 Sep; 171(2):303-313. PubMed ID: 29948405
[TBL] [Abstract][Full Text] [Related]
36. The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
Yang ZJ; Yu Y; Chi JR; Guan M; Zhao Y; Cao XC
Breast Cancer; 2018 May; 25(3):315-324. PubMed ID: 29353447
[TBL] [Abstract][Full Text] [Related]
37. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
[TBL] [Abstract][Full Text] [Related]
40. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
